Indications
Bronchospastic lung disease (asthma, COPD, wheezing). Also hyperkalemia
Contraindications
Hypersensitivity, tachycardia secondary to a heart condition
Adult dose
Bronchospasm (asthma, COPD): 2.5 mg nebulized for mild wheezing without distress. 5 mg nebulized or 6 puffs MDI for respiratory distress with bronchospasm. Repeat at this dose with unlimited frequency for ongoing distress
Anaphylaxis with wheezing: 2.5-5 mg nebulized
Airway irritant inhalation with wheezing: 2.5-5 mg nebulized or 4-8 puffs MDI
Hyperkalemia (crush injury, hyperglycemia): 5 mg nebulized. Can repeat if no response
Pediatric dose
Bronchospasm (age 2 and older): same doses as adults. 2.5 mg nebulized for mild wheezing, 5 mg nebulized or 6 puffs MDI for distress, repeat with unlimited frequency. Not weight-based
Anaphylaxis with wheezing (all ages): 2.5-5 mg nebulized
Bronchiolitis (under 2): no proven benefit from routine use
Route
Inhaled by nebulizer or metered dose inhaler (MDI)
Special considerations
Severe bronchospasm can be silent. If a known asthmatic has severe dyspnea, treat them even when you hear no wheezing.
You can give it in line with non-invasive ventilation.
It's mostly beta-2 with some beta-1 effect. It relaxes bronchial smooth muscle with little effect on heart rate.
Nebulizer droplets can spread germs, so consider putting a surgical mask over the nebulizer.
Follow your local protocols. Sources: National Model EMS Clinical Guidelines (NASEMSO, 2022): Respiratory Distress (Includes Bronchospasm, Pulmonary Edema); Anaphylaxis and Allergic Reaction; Airway Respiratory Irritants; Hyperglycemia; Crush Injury/Crush Syndrome; Pediatric Respiratory Distress (Bronchiolitis). Levels from the National EMS Scope of Practice Model (2019).